TechnologyExosome-based therapeutics for localized diseases
Microfluidic chip technology is for isolation, purification, and identification of disease-derived biomarkers in a liquid biopsy using the fluid inertia in microfluidic channels.
TheDABOM Inc. has microfluidic-based platforms for isolation, purification, and identification of biomarkers,which has the advantages of high efficiency, low cost, and no limitation on the amount of sample volume.
Elution
TheDABOM Inc. provides user-friendly automation systems for biomedical analysis.